Search

Your search keyword '"TABARSI, Payam"' showing total 1,163 results

Search Constraints

Start Over You searched for: Author "TABARSI, Payam" Remove constraint Author: "TABARSI, Payam"
1,163 results on '"TABARSI, Payam"'

Search Results

1. Trends in multidrug-resistant tuberculosis in Tehran, Iran: an analysis of published data

9. Report on adverse events of COVID-19 vaccines in Iran: a comprehensive national prospective longitudinal analysis.

10. Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses

11. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis

12. Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis

17. Transmission electron microscopy study of suspected primary ciliary dyskinesia patients

18. No clinical benefit of high dose corticosteroid administration in patients with COVID-19: A preliminary report of a randomized clinical trial

20. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study

21. Combination therapy of IFNβ1 with lopinavir–ritonavir, increases oxygenation, survival and discharging of sever COVID-19 infected inpatients

22. C1q Levels: A Reliable Biomarker for Differentiating Active and Latent Tuberculosis Infection.

24. Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study

25. Mortality in adults with multidrug-resistant tuberculosis and HIV by antiretroviral therapy and tuberculosis drug use: an individual patient data meta-analysis

27. Mendelian Susceptibility to Mycobacterial Disease (MSMD): Clinical and Genetic Features of 32 Iranian Patients

30. Investigating the Seroconversion Patterns of Specific Antibodies Against Various Antigens of SARS-CoV-2 in Hospitalized COVID-19 Patients and Vaccinated Individuals

31. Another step toward final call on Remdesivir efficacy as a treatment for hospitalized COVID-19 patients: a multicenter open-label trial

32. Evaluation of the time-dependent effects of factors influencing the hazard of disease recurrence in tuberculosis patients

37. Long-standing COVID-19 Disease in Immunocompromised and Immunocompetent Patients; Case Reports and Literature Review.

38. Characterization of QuantiFERON Severe Acute Respiratory Syndrome Coronavirus 2 and Anti-severe Acute Respiratory Syndrome Coronavirus 2 Nucleocapsid and S1 Spike Protein Antibodies in Vaccinated and Unvaccinated Coronavirus Disease 2019 Patients.

39. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis

49. Efficacy and safety of an inactivated virus-particle vaccine for SARS-CoV-2, BIV1-CovIran: randomised, placebo controlled, double blind, multicentre, phase 3 clinical trial

Catalog

Books, media, physical & digital resources